Boston Scientific to expand CRM footprint with Cameron Health buy

03/8/2012 | Wall Street Journal, The

Boston Scientific hopes to strengthen its foothold in the cardiac rhythm management market with the acquisition of Cameron Health, maker of the S-ICD wireless defibrillator. The deal calls for Boston Scientific to pay $150 million upfront in cash and possibly $150 million more upon FDA approval of the S-ICD system, plus as much as $1.05 billion in potential milestone payments during the course of the six years immediately after FDA approval.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX